Takeda Pharmaceutical (TAK) Change in Acquisitions & Divestments (2018 - 2026)

Takeda Pharmaceutical's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at -$497.1 million for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments rose 32.0% year-over-year to -$497.1 million; the TTM figure through Jun 2026 stood at $194.8 million (up 1107.06% YoY), while the FY2026 annual figure was -$18.4 million, down 152.76% from the prior year.
• Change in Acquisitions & Divestments for Q2 2026 stood at -$497.1 million, down from -$110.4 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $531.3 million in Q1 2025, with the low at -$731.1 million in Q2 2025.
• The 5-year median for Change in Acquisitions & Divestments is -$34.7 million (2022), against an average of -$37.4 million.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments plunged 707.49% in 2023, then jumped 845.37% in 2025.
• Takeda Pharmaceutical's Change in Acquisitions & Divestments stood at $234.6 million in 2022, then retreated by 21.76% to $183.6 million in 2023, then soared by 33.53% to $245.1 million in 2024, then surged by 30.79% to $320.6 million in 2025, then sank by 255.07% to -$497.1 million in 2026.
• Business Quant data shows TAK's Change in Acquisitions & Divestments at -$497.1 million in Q2 2026, -$110.4 million in Q1 2026, and $320.6 million in Q4 2025.